Swiss drug maker Novartis AG reported a 2% rise in fourth-quarter net income Wednesday that missed expectations as growing sales of its newest products failed to offset a slowdown in an older but ... more 
Swiss drug maker Novartis AG reported a 2% rise in fourth-quarter net income Wednesday that missed expectations as growing sales of its newest products failed to offset a slowdown in an older but still important drug. Net income rose to $2.06 billion from $2.02 billion a year earlier, but missed analyst forecasts of $2.4 billion. Basel-based Novartis forecast sales would grow in the low to mid-single digits. less 
1 / 23
Wochit
Wed, Jan 29, 2014 9:42 AM EST